| Literature DB >> 35388580 |
Eran Y Bellin1, Alice M Hellebrand2, Steven M Kaplan2, Jordan G Ledvina2, William T Markis3, Nathan W Levin4, Allen M Kaufman2.
Abstract
INTRODUCTION: Post-dialysis recovery time (DRT) has an important relationship to quality of life and survival, as identified in studies of ESRD patients on conventional dialysis. ESRD patients are often discharged from hospitals to skilled nursing facilities (SNFs) where on-site treatment using home hemodialysis technology is increasingly offered, but nothing is known about DRT in this patient population.Entities:
Keywords: ESRD; home hemodialysis; more frequent dialysis; mortality; nursing home; post-dialysis recovery time
Mesh:
Year: 2022 PMID: 35388580 PMCID: PMC9543222 DOI: 10.1111/hdi.13012
Source DB: PubMed Journal: Hemodial Int ISSN: 1492-7535 Impact factor: 1.543
Recovery time reports in all dialysis sessions
| Recovery time category | Dialysis sessions (% total) ( | Cumulative percent of dialysis sessions with recovery reports ( |
|---|---|---|
| 0–½ h | 81,020 (32.0%) | 59.5% |
| ½–1 h | 26,760 (10.6%) | 79.1% |
| 1–2 h | 17,513 (6.9%) | 91.9% |
| 2–4 h | 5835 (2.3%) | 96.2% |
| 4–8 h | 1689 (0.7%) | 97.5% |
| 8–12 h | 1305 (0.5%) | 98.4% |
| By next morning | 1701 (0.7%) | 99.7% |
| Not even by next morning | 457 (0.2%) | 100% |
| N/A—cognitive deficit | 16,105 (6.4%) | |
| N/A—physical impediment | 755 (0.3%) | |
| Not asked/recorded | 100,127 (39.5%) |
Abbreviation: N/A, not applicable.
Clinical description of first eligible dialysis in DRT and excluded cohorts
| DRT ( | Excluded ( | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Mean (SD) | Percentiles |
| Mean (SD) | Percentiles | |||||||||
| 5th | 25th | 50th | 75th | 95th | 5th | 25th | 50th | 75th | 95th | |||||
| Age | 2309 | 68 (12) | 46 | 61 | 69 | 76 | 86 | 2489 | 69 (12) | 48 | 63 | 71 | 78 | 87 |
| Gender | ||||||||||||||
| Female | 1090 (47%) | 1164 (47%) | ||||||||||||
| Male | 1219 (53%) | 1325 (53%) | ||||||||||||
| Race/ethnicity | ||||||||||||||
| White | 927 (40%) | 981 (39%) | ||||||||||||
| Black | 696 (30%) | 916 (37%) | ||||||||||||
| Hispanic | 204 (9%) | 221 (9%) | ||||||||||||
| Other/unknown | 482 (21%) | 371 (15%) | ||||||||||||
| Vintage (years) | 1477 | 2.5 (3.5) | 0 | 0 | 1 | 5 | 9 | 1891 | 5.6 (14.6) | 0 | 0 | 1 | 5 | 11 |
| IDH during the reported dialysis | 408 (18%) | 390 (24%) | ||||||||||||
| sBP Increase (PostHD sBP—PreHD sBP) >5 | 902 (39%) | 1046 (42%) | ||||||||||||
| Pre‐HD sBP | 2309 | 131 (29) | 98 | 111 | 129 | 150 | 178 | 2489 | 127 (28) | 90 | 109 | 124 | 144 | 175 |
| Post‐HD sBP | 2309 | 130 (26) | 98 | 111 | 127 | 146 | 174 | 2489 | 127 (27) | 93 | 111 | 125 | 143 | 174 |
| Net fluid removed (L) | 2225 | 0.87 (0.82) | −0.3 | 0.2 | 0.8 | 1.4 | 2.2 | 2460 |
0.89 (2.4) | −0.3 | 0.2 | 0.7 | 1.2 | 2.2 |
| UFR (ml/h/kg) | 1880 | 4.54 (3.3) | 0 | 2.25 | 4.22 | 6.47 | 9.80 | 2108 | 4.9 (12.3) | 0 | 2.1 | 3.9 | 6.3 | 9.7 |
| Length of stay (days) (uncensored) | 2060 | 71 (102) | 15 | 22 | 35 | 72 | 246 | 2329 | 35 (76) | 3 | 8 | 14 | 28 | 140 |
| Charlson index score | 2269 | 3.6 (2) | 2 | 2 | 3 | 5 | 7 | 2011 | 3.9 (2) | 1 | 2 | 3 | 5 | 7 |
| Acute MI | 69 (3%) | 74 (4%) | ||||||||||||
| CHF | 676 (30%) | 592 (29%) | ||||||||||||
| PVD | 256 (11%) | 192 (10%) | ||||||||||||
| Cerebrovascular | 292 (13%) | 242 (12%) | ||||||||||||
| Dementia | 114 (5%) | 66 (3%) | ||||||||||||
| COPD | 384 (17%) | 298 (15%) | ||||||||||||
| Rheumatologic disease | 17 (0.7%) | 44 (2%) | ||||||||||||
| Peptic ulcer | 14 (0.6%) | 28 (1%) | ||||||||||||
| Liver (mild) | 84 (4%) | 70 (4%) | ||||||||||||
| Liver mod/severe | 17 (0.7%) | 12 (0.6%) | ||||||||||||
| Diabetes | 509 (22%) | 419 (21%) | ||||||||||||
| Diabetes with complications | 599 (26%) | 383 (19%) | ||||||||||||
| Hemiplegia/paraplegia | 19 (0.8%) | 9 (0.4%) | ||||||||||||
| Renal disease | 2112 (93%) | 1828 (91%) | ||||||||||||
| Cancer | 85 (3.7%) | 103 (5%) | ||||||||||||
| Cancer with Metastasis | 6 (0.3%) | 8 (0.4%) | ||||||||||||
| AIDS | 18 (0.8%) | 12 (0.6%) | ||||||||||||
| Primary access | 2300 | 2249 | ||||||||||||
| HD catheter tunneled | 1257 (55%) | 1266 (56%) | ||||||||||||
| AV fistula | 749 (33%) | 721 (32%) | ||||||||||||
| AV Graft | 255 (11%) | 206 (9%) | ||||||||||||
| Miscellaneous | 39 (2%) | 56 (2%) | ||||||||||||
| Outcome of dialytic episode | 2309 | 2489 | ||||||||||||
| Censored | 249 (11%) | 160 (9%) | ||||||||||||
| Death | 225 (10%) | 282 (11%) | ||||||||||||
| Discharge | ||||||||||||||
| Hospital | 1009 (44%) | 1109 (45%) | ||||||||||||
| Home | 483 (21%) | 503 (20%) | ||||||||||||
| Unspecified | 286 (12%) | 378 (15%) | ||||||||||||
| HD Withdrawn or patient recovered | 57 (3%) | 57 (2%) | ||||||||||||
Abbreviations: AIDS, acquired immunodeficiency syndrome; AV, arteriovenous; CHF, congestive heart failure; COPD, Chronic obstructive pulmonary disease; DRT, post‐Dialysis Recovery Time; HD, hemodialysis; IDH, intradialytic hypotension; MI, myocardial infarction; PVD, peripheral vascular disease; sBP, systolic blood pressure; SD, standard deviation.
FIGURE 1Cumulative incidence of mortality or hospitalization from the first dialysis with recovery time attestation through day 90, comparing synthetic patients with constant recovery time ≤2 h versus synthetic patients with constant recovery time >2 h. Rapid recovery (≤2 h) was associated with reduced mortality or hospitalization (p = 0.04). Analysis was performed on dialytic episodes with recovery time subintervals defined according to Anderson–Gill methodology
Odds of rapid recovery time ≤2 h by mixed model logistic regression (n = 2309)
| Variable | Odds ratio (95% confidence interval) |
|
|---|---|---|
| Gender | ||
| Male | 1 (base) | |
| Female | 0.89 (0.68, 1.2) | 0.4 |
| Age category | ||
| 0–50 | 2.2 (1.3, 3.7) | 0.002 |
| 50–60 | 0.98 (0.70, 1.4) | 0.9 |
| 60–70 | 1 (base) | |
| 70–80 | 1.1 (0.81, 1.4) | 0.6 |
| ≥80 | 0.97 (0.65, 1.5) | 0.9 |
| Race/ethnicity | ||
| White | 1 | |
| Black | 0.81 (0.59, 1.1) | 0.2 |
| Hispanic | 2.4 (1.4, 4.1) | 0.001 |
| Other/unknown | 1.3 (0.91, 2.0) | 0.14 |
| Number of dialyses in the antecedent week | ||
| <5 | 1 (base) | |
| ≥5 | 1.2 (1.1, 1.3) | 0.000 |
| Intradialytic hypotension | 0.91 (0.84, 0.99) | 0.025 |
| Post‐HD—Pre‐HD sBP >5 mmHg | 1.03 (0.96, 1.1) | 0.43 |
| Time since last treatment (days) | 1.02 (0.99, 1.1) | 0.24 |
| Missed antecedent dialysis | 0.73 (0.64, 0.83) | 0.000 |
| Pre‐HD sBP category | ||
| 0–119 | 0.95 (0.88, 1.03) | 0.22 |
| 120–139 | 1 (Base) | |
| 140–159 | 1.02 (0.93, 1.1) | 0.72 |
| 160–179 | 1.2 (1.07, 1.4) | 0.002 |
| ≥180 | 0.97 (0.80, 1.15) | 0.71 |
Abbreviations: HD, hemodialysis; sBP, systolic blood pressure.
Conventional (3x/week) dialysis literature summary: Percent post‐dialysis recovery time (DRT) <1 and <2 h
| Study |
| Study/data type | % DRT <1 h | % DRT <2 h | Age (mean (SD)) |
|---|---|---|---|---|---|
| Guedes 2020 | 98,616 | Observational study of Incident patients (North America LDO). | 44.3% | 61.6% | 62.6 (14.4) |
| Rayner 2014 | 6040 | Random sample (12 Western countries) | — | 32.1% | 64.8 (14.0) |
| Hussein 2017 | 2689 | Cross‐sectional study (46 US facilities, 3 states) | — | 55% | 63 (median) |
| Lopes 2014 | 800 | Cross‐sectional study (Brazilian patients) | 84.9% | 93.0% | 49.0 (13.9) |
| Davenport 2018 | 701 | Cross‐sectional study (5 UK dialysis centers) | 24% | — | 64.1 (16.6) |
| Harford 2017 | 364 | Prospective cohort (includes 1572 sessions, 3 US facilities) | — | 52.1% | 59 (median) |
| Alvarez 2020 | 359 | Cross‐Sectional study (NKF survey database) | 21% | 39% | 62.5 (13.8) |
| Leme 2020 | 176 | Cross‐sectional study (South/Southeast Brazil) | 73.8% | 83.2% | 52.5 (14.9) |
| Jaber 2010 | 128 | Prospective Cohort measured at baseline on Conventional HD (US, Multicenter) | 19.0% | — | 52.0 (15.0) |
| Bossola 2013 | 100 | Cross sectional study (single site in Lazio, Italy) | — | 21% | 61.7 (16.2) |
| Ozen 2021 | 86 | Cross‐sectional study (Single site in Turkey) | 19.8% | 26.8% | 56.4 (14.2) |
| Garg 2017 | 86 | Conventional HD Arm of Daily Trial RCT: Baseline & 12‐month Per Protocol assessment. (Multicenter in US and Canada) | 20.5% (baseline), 37% (12 months) | — | 50.4 (13.9) |
| Brys 2020 | 45 | Cross‐sectional study (single site, Rome, Italy) | — | 53.3% | 63.0 (17.0) |
Note: Minimum dialysis vintage criteria are not specified in study methods unless otherwise indicated.
Abbreviations: DOPPS, dialysis outcomes and practice patterns study; HD, hemodialysis; HDFIT, Impact of Hemodiafiltration on Physical Activity and Self‐reported Outcomes: A Randomized Controlled Trial; KDQOL, kidney disease quality of life; LDO, large dialysis organization; NKF, national kidney foundation; PROHEMO, prospective study of the prognosis of chronic hemodialysis patients.
Dialysis vintage <180 days.
Dialysis vintage >60 days.
Dialysis vintage >3 months.
Dialysis vintage <24 months.
Dialysis vintage >6 months.
Dialysis vintage >1 year.